Hermes Biosciences
San Francisco
About Hermes Biosciences
Hermes Biosciences describes a benchtop, hands-off extracellular vesicle isolation system designed to purify exosomes quickly, efficiently, and reproducibly from any bodily fluid or cell culture media. This technology aims to advance research into exosome function and support clinical applications in oncology, degenerative disease, and regenerative medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.0M
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: hermesbio.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hermes-biosciences-106289 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.